BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38361145)

  • 1. Reassessing treatment strategies for DCIS: analysis of survival and recurrence patterns.
    Mokbel K; Alamoodi M
    Breast Cancer Res Treat; 2024 Jun; 205(2):423-424. PubMed ID: 38361145
    [No Abstract]   [Full Text] [Related]  

  • 2. Some clarity in the management of DCIS in breast cancer screening.
    Wald NJ
    J Med Screen; 2011; 18(3):112. PubMed ID: 22045817
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognosis of patients with locally recurrent breast cancer.
    Voogd AC; van Tienhoven G
    Am J Surg; 2007 Jan; 193(1):138. PubMed ID: 17188110
    [No Abstract]   [Full Text] [Related]  

  • 4. Ductal carcinoma-in-situ: long-term results of breast-conserving therapy.
    Mirza NQ; Vlastos G; Meric F; Sahin AA; Singletary SE; Newman LA; Kuerer HM; Ames FC; Ross MI; Feig BW; Pollock RE; Buchholz TA; McNeese MD; Strom EA; Hortobagyi GN; Hunt KK
    Ann Surg Oncol; 2000 Oct; 7(9):656-64. PubMed ID: 11034242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study.
    Vidali C; Caffo O; Aristei C; Bertoni F; Bonetta A; Guenzi M; Iotti C; Leonardi MC; Mussari S; Neri S; Pietta N
    Radiat Oncol; 2012 Oct; 7():177. PubMed ID: 23098066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative management of intraductal carcinoma (DCIS) of the breast. Collaborating NSABP investigators.
    Fisher ER; Leeming R; Anderson S; Redmond C; Fisher B
    J Surg Oncol; 1991 Jul; 47(3):139-47. PubMed ID: 1649353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ductal Carcinoma In Situ of the Breast: Controversies and Current Management.
    Barrio AV; Van Zee KJ
    Adv Surg; 2019 Sep; 53():21-35. PubMed ID: 31327448
    [No Abstract]   [Full Text] [Related]  

  • 9. The target for statins, HMG-CoA reductase, is expressed in ductal carcinoma-in situ and may predict patient response to radiotherapy.
    Butt S; Butt T; Jirström K; Hartman L; Amini RM; Zhou W; Wärnberg F; Borgquist S
    Ann Surg Oncol; 2014 Sep; 21(9):2911-9. PubMed ID: 24777857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Margins in DCIS: Does Residual Disease Provide an Answer?
    Morrow M; Van Zee KJ
    Ann Surg Oncol; 2016 Oct; 23(11):3423-3425. PubMed ID: 27165722
    [No Abstract]   [Full Text] [Related]  

  • 11. Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation.
    Pilewskie M; Olcese C; Eaton A; Patil S; Morris E; Morrow M; Van Zee KJ
    Ann Surg Oncol; 2014 May; 21(5):1552-60. PubMed ID: 24385207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of early-stage breast cancer.
    Curr Probl Cancer; 1999; 23(4):149-228. PubMed ID: 10485445
    [No Abstract]   [Full Text] [Related]  

  • 13. Controversies in the Treatment of Ductal Carcinoma in Situ.
    Barrio AV; Van Zee KJ
    Annu Rev Med; 2017 Jan; 68():197-211. PubMed ID: 28099081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of DCIS--results from clinical trials.
    Cuzick J
    Surg Oncol; 2003 Dec; 12(4):213-9. PubMed ID: 14998562
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of ductal carcinoma in situ on the outcome of invasive breast cancer. A prospective cohort study.
    Lopez Gordo S; Blanch Falp J; Lopez-Gordo E; Just Roig E; Encinas Mendez J; Seco Calvo J
    Int J Surg; 2019 Mar; 63():98-106. PubMed ID: 30738200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductal carcinoma in situ (DCIS) of the breast--a therapeutic dilemma.
    van Dongen JA; Bartelink H; Fentiman IS; Peterse JL
    Eur J Surg Oncol; 1987 Apr; 13(2):123-5. PubMed ID: 3030824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
    Narod SA; Iqbal J; Giannakeas V; Sopik V; Sun P
    JAMA Oncol; 2015 Oct; 1(7):888-96. PubMed ID: 26291673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actual management of ductal carcinoma in situ of the breast.
    Maass N; Alkasi O; Bauer M; Jonat W; Souchon R; Meinhold-Heerlein I
    Arch Gynecol Obstet; 2009 Nov; 280(5):699-705. PubMed ID: 19259692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraductal carcinoma of the breast: pathologic features associated with local recurrence in patients treated with breast-conserving therapy.
    Goldstein NS; Kestin L; Vicini F
    Am J Surg Pathol; 2000 Aug; 24(8):1058-67. PubMed ID: 10935646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of care analysis among women with ductal carcinoma in situ in North Carolina.
    Jackson LC; Camacho F; Levine EA; Anderson RT; Stewart JH
    Am J Surg; 2008 Feb; 195(2):164-9. PubMed ID: 18096124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.